...
首页> 外文期刊>International Journal of Pharmaceutics >Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits
【24h】

Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits

机译:盐酸特比萘芬的有前途的离子敏感性原位眼用纳米乳胶:家兔房水中眼刺激和药物药代动力学的设计,体外表征和体内评估

获取原文
获取原文并翻译 | 示例
           

摘要

Terbinafine hydrochloride (T-HCl) is recommended for the management of fungal keratitis. To maintain effective aqueous humor concentrations, frequent instillation of T-HCl drops is necessary. This work aimed to develop alternative controlled-release in situ ocular drug-loaded nanoemulsion (NE) gels. Twelve pseudoternary-phase diagrams were constructed using oils (isopropyl myristate/Miglyol? 812), surfactants (Tween? 80/Cremophor? EL), a co-surfactant (polyethylene glycol 400) and water. Eight drug-loaded (0.5%, w/v) NEs were evaluated for thermodynamic stability, morphology, droplet size and drug release in simulated tear fluid (pH 7.4). Following dispersion in gellan gum solution (0.2%, w/w), the in situ NE gels were characterized for transparency, rheological behavior, mucoadhesive force, drug release and histopathological assessment of ocular irritation. Drug pharmacokinetics of sterilized F31 [Miglyol? 812, Cremophor ? EL: polyethylene glycol 400 (1:2) and water (5, 55 and 40%, w/w, respectively)] in situ NE gel and oily drug solution were evaluated in rabbit aqueous humor. The NEs were thermodynamically stable and have spherical droplets (30 nm). The gels were transparent, pseudoplastic, mucoadhesive and showed more retarded zero-order drug release rates. F31 in situ NE gel showed the least ocular irritation potential and significantly (P 0.01) higher Cmax, delayed Tmax, prolonged mean residence time and increased bioavailability. ? 2013 Elsevier B.V.
机译:建议使用盐酸特比萘芬(T-HCl)处理真菌性角膜炎。为了维持有效的房水浓度,必须经常滴加T-HCl滴剂。这项工作旨在开发替代的控释原位眼药载纳米乳(NE)凝胶。使用油(肉豆蔻酸异丙酯/Miglyol®812),表面活性剂(Tween®80 /Cremophor®EL),助表面活性剂(聚乙二醇400)和水构建十二个伪三元相图。在模拟的泪液(pH 7.4)中评估了八种载药(0.5%,w / v)的NE的热力学稳定性,形态,液滴大小和药物释放。在吉兰糖胶溶液(0.2%,w / w)中分散后,对原位NE凝胶进行表征,以确保透明性,流变行为,粘膜粘附力,药物释放和对眼睛刺激的组织病理学评估。无菌F31的药物药代动力学[Miglyol? 812,Cremophor吗? EL:在兔房水中评估原位NE凝胶和油性药物溶液的聚乙二醇400(1:2)和水(分别为5%,55%和40%,w / w)。 NE具有热力学稳定性,并具有球形液滴(<30 nm)。该凝胶是透明的,假塑性的,粘膜粘附的,并且显示出更多的延迟的零级药物释放速率。 F31原位NE凝胶显示出最小的眼刺激潜力,并且显着(P <0.01)Cmax高,Tmax延迟,平均停留时间延长和生物利用度增加。 ? 2013 Elsevier B.V.

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号